DIALYSIS 362784
A dialysis facility in OH. It ran an operating surplus of 16.4% in FY22 on $2.8M of operating revenue. Operating margin declined from 24.6% in FY20 to 16.4% in FY22.
The money
$ thousands · HCRIS cost-report basis · as filed, QA-gatedRatios tell you how this dialysis facility is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio computes only when every input is reported in the filing (otherwise its cell states which input is Not reported in source); a year whose balance sheet does not reconcile is labeled, and its derived ratios read Astrelis calculation unavailable. Not audited by Astrelis.
| Line item | FY20 | FY21 | FY22 |
|---|---|---|---|
| Patient revenue | 4,159 | 4,238 | 2,802 |
| Total operating revenue | 4,159 | 4,238 | 2,802 |
| Total operating expenses | 3,135 | 2,861 | 2,342 |
| Operating income | 1,024 | 1,377 | 460 |
| Operating margin % | +24.6% | +32.5% | +16.4% |
| Other non-operating, net | 93 | 48 | 1 |
| Net income | 1,117 | 1,425 | 461 |
| Net income % | +26.3% | +33.3% | +16.4% |
Trajectory
State context
16.4% operating margin in FY22.
Operating margin declined 16.1 points vs FY21 — the briefing traces why, line by line.
Reserve The Board Briefing →The Board Briefing
The record's final filed years, benchmarked against the peer pools of their own era and labeled so on every exhibit.